Covid-19. Coronavirus disease (COVID-19)
Conditions
Interventions
Intervention 1: Intervention group: is performed by a researcher who does not know the assignment of groups under the supervision of an Acu-TENS trained physiotherapist for the intervention group in s
The electrodes are connected to NOVIN701P PLUS-STIMULATOR device made in Iran and serial number AX212088 and the frequency is set to 4 Hz and the pulse is set to 200 MICROSEC with a duration of 45 min
Sponsors
Shahroud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Confirmation of Covid-19 diagnosis based on PCR test results or CT Scan findings (Ground Glass view) by physician Age over 18 and under 70 years Use the same treatment protocol for patients Existence of moderate pulmonary involvement (SpO2 between 90 to 93% and pulmonary involvement less than 50%) and the patient being in the second phase of Covid-19 disease according to the guideline of the Ministry of Health
Exclusion criteria
Exclusion criteria: Drug addiction Cigarette addiction Advanced metastatic cancer Congestive heart failure (grades 3 and 4) Kidney failure requires dialysis History of mechanical ventilation before intervention Existence of cardiac pacemaker Cardiac conduction disorders History of allergies and skin sensitivities in the area of ??the electrodes The presence of a skin lesion in the area where the electrodes are placed Hospitalized patients with other clinical manifestations of Covid-19 and no pulmonary involvement Continuous use of bronchodilators Having liver failure Moderate to severe scoliosis Obesity (BMI above 35) Psychological illnesses lead to lack of patient cooperation Cerebrovascular disorders Having COPD Having uncontrolled diabetes Inability and prohibition to be in a semi-sitting position for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of arterial blood oxygen saturation. Timepoint: Daily for up to 4 days before and after the intervention. Method of measurement: Finger pulse oximeter device and monitor.;Need for mechanical ventilation. Timepoint: 4, 8 and 12 days after the intervention. Method of measurement: Checklist.;Death and survival. Timepoint: until the end of hospitalization. Method of measurement: Checklist.;Vital signs (RR,HR). Timepoint: Daily for up to 4 days before and after the intervention. Method of measurement: Count the respiratory rate and heart rate in a minute and record them in a checklist.;Severity of breathing (Dyspnea). Timepoint: Daily for up to 4 days before and after the intervention. Method of measurement: Visual Analogue scale for dyspnea (VASD). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboobeh Khajeh
Shahroud University of Medical Sciences
Outcome results
None listed